- Country: Chile
- Summary: Adq. of Medications and Supplies for the Ssbb.
- CLT Ref No: 118797465
- Deadline: 19 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CLP 170771370
- Notice Type: Tender
- Document Ref. No.: 1058023-5-LP25
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- According to acquisition applications NO15, Folio BDSS211585, N18, Folio BDSS211534 and N23 folio BDSS211790 issued from the Department of Networks and Specialties of the Biobio Health Service, in which the acquisition of medicines and supplies is requested to meet the needs of programs andFailure of Cenabast.
Products or services: Pioglyitazone hydrochloride, clindamycin, metronidazole, mometassone furoate, hydroxizine hydroxizin, ketoconazole, cycloypirox, mupirocin, terbinafine hydrochloride, cetirizine, thirting, tacrolim, tacrolim, levonorgestry Etinil, combinationof ethonogestrel and ethinylstradiol, metformin hydrochloride - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAdq. of Medications and Supplies for the Ssbb. - Chile Tender
The BIO BIO HEALTH SERVICE, a Government sector organization in Chile, has announced a new tender for Adq. of Medications and Supplies for the Ssbb.. This tender is published on ChileTenders under CLT Ref No: 118797465 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-19.
The estimated tender value is CLP 170771370, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
